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Clinical Correlates and Mayo Clinic Risk ScoreTo the Editor: Apical ballooning syndrome (ABS) is an acute
cardiac syndrome characterized by transient regional systolic dys-
function of the left ventricle (LV) in the absence of obstructive
coronary artery disease (1). Systolic heart failure (HF) is the most
common complication and merits early detection and treatment.
However, the clinical correlates and outcomes of acute HF in ABS
have not been systematically studied. Thus, the primary aim of our
study was to examine the frequency of, risk factors for, and
prognosis of patients with acute HF complicating ABS.
A retrospective analysis was conducted among 118 consecutive,
prospectively identified patients with ABS diagnosed using the
Mayo Clinic criteria from January 2002 to January 2008 (1). The
study was approved by the Institutional Review Board and all
patients consented to the use of their medical records for research
purposes. Acute heart failure was defined as a clinical syndrome
characterized by new onset of symptoms such as dyspnea, and at
least 2 of the following physical signs: pulmonary rales, elevated
central venous pressure, and a third heart sound on cardiac
auscultation; cardiogenic shock was defined using standard criteria
(2). Coronary angiography was performed on hospital days 1, 2, 3,
and 4 in 98, 15, 4, and 1 patient, respectively. Ejection fraction
(EF) was measured by LV angiography in 92 patients. Echocar-
diography was performed in 106 patients at a mean interval of
1.7  1.0 days. A follow-up echocardiogram was available in 94
patients at a mean interval of 75  14 days. Independent
predictors for the development of acute HF were identified using
the Cox proportional hazards regression model. Five clinical
characteristics (age, presence of physical stressor, ST-segment
elevation, troponin T level at admission, and EF) that had a
statistically significant association with acute HF by univariate
analysis were included in the multivariate model. The risk score for
acute HF was developed by allocating 1 point each for 3 factors
that were significant (p 0.05) in multivariate analysis arranged in
a dichotomous fashion (age 70 years, presence of physical
stressor, and EF 40%). Troponin T level was not included in the
risk score due to the heterogeneity in the assays and cutoff values
used in different institutions. The chi-square test was used to assess
differences in the event rates for increasing risk score, and its
predictive performance was evaluated using the C-statistic. The
risk score was validated in a second cohort of 52 ABS patients
identified between February 2008 and December 2009.
Fifty-three (45%) patients demonstrated clinical evidence of
acute HF during the hospitalization (Table 1). Among patients
with acute HF, 23 (43%), 5 (9%), and 25 (47%) patients had Killip
class II, III, and IV HF, respectively. Patients with acute HF were
older, more likely to have experienced a preceding physically
stressful event, and had higher admission and peak cardiac tro-
ponin T levels, more frequent ST-segment elevation, and lowerEF at presentation. By multivariate analysis, age (odds ratio [OR]:
1.06 [95% confidence interval (CI): 1.02 to 1.11], p  0.001), a
physical stressor (OR: 4.01 [95% CI: 1.64 to 10.36], p  0.002),
admission troponin T level (OR: 2.43 [95% CI: 1.05 to 6.59], p 
0.04), and lower EF (OR: 0.96 [95% CI: 0.92 to 0.99], p  0.01)
were independent predictors of acute HF. There was a significant
positive correlation between the frequency of acute HF and the risk
score in the development cohort (C-statistic 0.77, p 0.001) (Fig. 1).
Twenty (38%) patients in the validation cohort (age 71 12 years,
46% physical trigger, EF: 42 12%) developed HF, and there was
a significant increase in the frequency of HF as the risk score
increased (C-statistic 0.77, p  0.002) (Fig. 1). Patients with HF
were more likely to require inotrope (38% vs. 0%), intra-aortic
balloon pump support (17% vs. 0%), mechanical ventilation (28%
vs. 5%), and experienced longer hospitalization (11.2  5.4 days
vs. 5.4  8.7 days, p  0.0004) compared to those without HF.
Three (3%) patients died in hospital due to multi-organ failure
secondary to cardiogenic shock. The majority (92%) of patients
had complete resolution of acute HF at discharge from the
hospital. Patients with and without HF had similar EF (60 10%
vs. 62  6%, p  0.3) on follow-up. None of the patients had
ongoing or recurrent HF at follow-up.
Our study is the first, to our knowledge, to provide a measure of
the severity of HF in ABS. We report that approximately 45% of
patients had clinical HF, and approximately 1 in 5 developed
cardiogenic shock. Patients who developed acute HF had greater
myocardial injury and stunning, and were more likely to have a
physical stressor and advanced age. There are several potential
explanations for these observations. First, patients with physical
stressors had significant underlying comorbid conditions that not
only triggered ABS, but may have contributed to the development
of HF. Second, physical stressors such as post-operative state may
be associated with a more sustained surge in catecholamines
compared with emotional stress which may be short lived. Third,
advancing age is often associated with higher prevalence of
pre-existing cardiac abnormalities such as diastolic dysfunction and
coronary endothelial dysfunction, which may increase the likeli-
hood of developing HF.
We also developed and validated a simple risk score that can be
calculated at the time of presentation. The presence of 1, 2, and 3
points was associated with a 28%, 58%, and 85% risk of acute HF,
respectively. Despite the limitations of retrospective analysis, the
model had good predictive value in the validation cohort, which
suggests that it may be widely applicable to patients with ABS that
are diagnosed according to the Mayo Clinic diagnostic criteria.
Risk stratification using this data may assist in triaging patients at
high risk to an intensive care unit for initial management. In
addition, it may allow physicians to identify patients in whom early
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since ABS is believed to be catecholamine mediated, the use of
inotropic agents in those with hypotension or HF, or at increased risk
Clinical Characteristics of ABS Patients With and Without Acute HFTable 1 Clinical Characteristics of ABS P tients With and Without Acut
All Patients (n  118
Age, yrs 70 13
Females 115 (97%)
Symptom onset to presentation, days 1.3 0.8
Presenting symptom
Chest pain 74 (63%)
Dyspnea 61 (52%)
Precipitating factor
Emotional stress 30 (25%)
Physical stress 60 (51%)
Cardiovascular risk factors
Hypertension 73 (62%)
Diabetes mellitus 15 (13%)
Electrocardiogram
ST-segment elevation 54 (46%)
Deep T-wave inversion 65 (55%)
Cardiac biomarkers
Admission troponin T, ng/ml 0.52 0.67
Peak troponin T, ng/ml 0.71 0.75
BNP, pg/ml* 1,011 927
Angiographic characteristics
Ejection fraction, % 41 13
LV end-diastolic pressure, mm Hg 25 7
Grade 3 or 4 mitral regurgitation 13 (14%)
Admission echocardiogram
Ejection fraction, % 40 13
Right ventricular systolic pressure, mm Hg 45 13
Wall motion score index 1.89 0.47
Data are expressed as n (%) or mean  SD. *n  48.
ABS  apical ballooning syndrome; HF  heart failure; LV  left ventricular.
Figure 1 Acute Heart Failure in Apical Ballooning Syndrome
Frequency of heart failure stratified by the risk score
in the development (A) and validation (B) cohorts.for developing HF may potentially be deleterious. Thus, inotropic
agents should be used with caution in ABS, and the use of intra-aortic
balloon pump counterpulsation may be the preferred treatment
strategy for moderate or severe hemodynamic compromise.
Malini Madhavan, MBBS
Charanjit S. Rihal, MD
Amir Lerman, MD
*Abhiram Prasad, MD
*Mayo Clinic
200 First Street SW
Rochester, Minnesota 55905
E-mail: prasad.abhiram@mayo.edu
doi:10.1016/j.jacc.2010.10.038
EFERENCES
1. Prasad A, Lerman A, Rihal CS. Apical ballooning syndrome (Tako-
Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarc-
tion. Am Heart J 2008;155:408–17.
2. Hasdai D, Topol EJ, Califf RM, Berger PB, Holmes DR Jr. Cardio-
genic shock complicating acute coronary syndromes. Lancet 2000;356:
No Acute HF (n  65) Acute HF (n  53) p Value
67 12 73 12 0.02
63 (97%) 52 (98%) 0.70
1.3 1.0 1.2 0.5 0.30
51 (78%) 23 (43%) 0.0001
26 (40%) 35 (66%) 0.005
0.0003
19 (30%) 11 (21%)
23 (35%) 37 (70%)
40 (62%) 33 (62%) 0.90
7 (11%) 8 (15%) 0.50
23 (36%) 31 (58%) 0.01
39 (60%) 26 (49%) 0.20
0.37 0.42 0.71 0.85 0.009
0.55 0.56 0.93 0.90 0.01
783 753 1,161 1,010 0.10
46 11 35 13 0.0001
23 7 28 7 0.001
5 (10%) 8 (21%) 0.08
44 13 36 13 0.004
41 11 49 14 0.006
1.74 0.41 2.05 0.47 0.0006e HF
)749–56.
